Nucleoside-based Derivative Production Service
Functions of Nucleoside Derivatives
As research on a range of modified nucleosides has taken off in the fields of chemistry, biology, and pharmacology worldwide, a large number of nucleoside derivatives have been designed and developed. Nucleoside derivatives have structural similarities to natural nucleosides. They can interfere with or directly act on the metabolic process of nucleic acids to interfere with or prevent the production of nucleic acids or proteins. Therefore, nucleoside derivatives are of great significance and practical value in the fields of chemistry, life science, and medicine. It has been found that many nucleoside derivatives show good antibacterial, antiviral, antitumor effects, etc., and show superiority in new anticancer and antiviral aspects. For example, 5-fluorouracil deoxyriboside can play an antitumor role. Its toxicity is not as high as that of 5-fluorouracil, and it is effective against a variety of cancers.
Nucleoside-based Derivative Production Services at CD BioGlyco
CD BioGlyco aims to provide convenient nucleoside derivative production services to clients in various fields. In order to make production more efficient, we are equipped with complete experimental instruments and testing equipment. We have the ability to cope with various difficult productions.
- Nucleoside derivatives production service
We produce nucleoside derivatives by chemical synthesis, enzymatic synthesis, etc. Chemical synthesis is capable of producing a wide range of structurally novel compounds. We produce more types of nucleoside derivatives by chemical synthesis. Enzymatic synthesis has more advantages such as mild reaction conditions, high selectivity, and production of products with a single structure. This method has better application prospects in the production of nucleoside derivatives. We have first-class testing equipment to analyze the structure. We will complete all the experiments from R&D to bioactivity assay according to clients' needs.
Fig.1 Production process of nucleoside derivatives. (CD BioGlyco)
- Modification of nucleoside derivatives
The modification of nucleoside derivatives is generally based on the structure of natural nucleosides or active nucleoside analogs. We carry out the corresponding structural modifications in terms of sugar rings, bases, and conformations.
Fig.2 Methods of structural modification of nucleoside analogs. (CD BioGlyco)
Base modifications can be categorized as five-membered cyclic bases, six-membered heterocyclic bases, bicyclic bases, sulfur-containing heterocyclic bases, etc. The modified bases are then linked to the glycosyl group structure to obtain nucleoside analogs. There are more antiviral types of such compounds. Their activity will vary in expression depending on the cell type.
Glycosyl group structures have a large number of modification sites. Most of the nucleoside analogs used in clinical applications are glycosyl-modified derivatives. Nucleoside analogs with higher activity can be screened by changing the sugar group structure. It can also further improve the efficacy and pharmacokinetic properties of known drugs and reduce toxic side effects to some extent. Modification of the sugar moiety can be categorized into substitution modification of the sugar ring and modification of the sugar ring structure. According to the substitution at different positions on the sugar ring, our glycosyl group modifications are categorized as 2'-substitution, 3'-substitution, 4'-substitution, 5'-substitution, 2',3'-dideoxy, heteronucleotide, etc. According to the sugar ring structure modification is divided into heterocyclic nucleosides, carbocyclic nucleosides, open ring nucleosides, unsaturated nucleosides, and so on.
- Glycosyl group and base modification at the same time.
In order to enhance the drug activity of nucleoside analogs, improve therapeutic specificity, and reduce the toxicity of the drug, the base and sugar groups are usually modified at the same time.
- Conformational transformation.
Based on the chiral center at the 1'-position, nucleoside analogs are classified into α-conformational and β-conformational nucleosides. Based on mirror symmetry, nucleosides are further classified into D- and L-nucleosides. There are two main types of nucleoside conformational changes, splicing of α- and β-configurations, and conversion of L- and D-configurations.
Applications
- The modification of different types of nucleosides helps in the production of a wide range of structurally different compounds. This also helps in enriching the diversity of nucleoside derivatives.
- Modification of different sites of nucleosides has been used to develop various novel polymerizable drug derivatives.
- Nucleoside derivatives are often used to prepare some complex functionalized self-assemblies. Nucleoside derivatives with different structures are used to study their self-assembly behavior in solution as well as on solid surfaces.
Advantages
- We are familiar with a wide range of reaction types such as condensation, alkylation, etc., and are adept at producing nucleoside derivatives using a variety of chemical methods.
- Nucleoside modifications contribute to the production of compounds with a wide range of activities. We modify nucleosides in terms of sugar rings, bases, and conformations. Nucleoside analogs of different structures can be produced.
- We have a large number of sophisticated testing instruments and various types of specialized analytical equipment to shorten the experimental period and increase the efficiency of production.
CD BioGlyco has developed a range of nucleoside modification methods, including modification of bases and sugar groups, and conformational changes. We have successfully produced various nucleoside derivatives. Please feel free to contact us for more information about nucleoside derivatives production, price, and other details.
References
- Choi, J.S.; Berdis, A.J. Visualizing nucleic acid metabolism using non-natural nucleosides and nucleotide analogs. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. 2016, 1864(1): 165-176.
- Kozlovskaya, L.I.; et al. Antiviral activity spectrum of phenoxazine nucleoside derivatives. Antiviral Research. 2019, 163: 117-124.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform
- Nucleoside-based Deoxyadenosine Derivative Production Service
- Nucleoside-based Deoxycytidine Derivative Production Service
- Nucleoside-based Deoxyguanosine Derivative Production Service
- Nucleoside-based Deoxythymidine Derivative Production Service
- Nucleoside-based Deoxyuridine Derivative Production Service
- Nucleoside-based Dideoxynucleotide Derivative Production Service
- Nucleoside-based Adenosine Derivative Production Service
- Nucleoside-based Adenine Derivative Production Service
- Nucleoside-based Cytosine Derivative Production Service
- Nucleoside-based Cytidine Derivative Production Service
- Nucleoside-based Guanosine Derivative Production Service
- Nucleoside-based Guanine Derivative Production Service
- Nucleoside-based Uridine Derivative Production Service
- Nucleoside-based Uracil Derivative Production Service
- Nucleoside-based Thymine Derivative Production Service
- Nucleoside-based Ribothymidine Derivative Production Service
- Nucleoside-based Different Backbone Sugar-based Derivative Production Service




